BOLT | Bolt Biotherapeutics, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	159.78 Million	227.8 Million	307.71 Million	46.54 Million	48.44 Million	15.97 Million
Total Current Assets	105.53 Million	172.74 Million	189.16 Million	25.36 Million	35.9 Million	14.1 Million
Cash And Short Term Investments	102.18 Million	168.88 Million	186.21 Million	22.83 Million	34.82 Million	13.63 Million
Cash and Cash Equivalents	10.81 Million	9.24 Million	27.38 Million	5.54 Million	34.82 Million	13.63 Million
Short Term Investments	91.37 Million	159.64 Million	158.83 Million	17.29 Million	-	-
Net Receivables	1.3 Million	800 Thousand	200 Thousand	12 Thousand	300 Thousand	-
Inventory	-	-800 Thousand	-200 Thousand	-12 Thousand	-300 Thousand	-
Other Current Assets	2.04 Million	3.85 Million	2.94 Million	2.52 Million	1.07 Million	466 Thousand
Total Non-Current Assets	54.25 Million	55.06 Million	118.55 Million	21.18 Million	12.54 Million	1.87 Million
Net PPE	24.07 Million	28.52 Million	30.6 Million	16.38 Million	11.51 Million	1.44 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	28.17 Million	23.94 Million	85.34 Million	1.56 Million	584 Thousand	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	1.99 Million	2.59 Million	2.6 Million	3.23 Million	446 Thousand	433 Thousand
Other Assets	1.00	-	-	-	-	-
Total Liabilities	47.04 Million	56.3 Million	57.59 Million	151.48 Million	94.29 Million	31.91 Million
Total Current Liabilities	20.45 Million	23.11 Million	21.32 Million	11.26 Million	8.65 Million	2.75 Million
Account Payables	2.98 Million	3.59 Million	3.57 Million	1.59 Million	2.09 Million	892 Thousand
Tax Payables	-	-	-	-	-	-
Short Term Debt	2.78 Million	2.39 Million	2.5 Million	1.5 Million	3.09 Million	40 Thousand
Deferred Revenue	2.2 Million	1.99 Million	2.86 Million	1.5 Million	599 Thousand	-
Other Current Liabilities	12.48 Million	15.14 Million	12.38 Million	6.66 Million	2.86 Million	1.82 Million
Total Non Current Liabilities	26.58 Million	33.18 Million	36.27 Million	140.22 Million	85.63 Million	29.16 Million
Long-Term Debt	17.43 Million	20.22 Million	21.85 Million	9.37 Million	7.08 Million	-
Deferred Revenue Non Current	9.1 Million	12.92 Million	14.2 Million	-	972 Thousand	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	43 Thousand	42 Thousand	210 Thousand	130.84 Million	71 Thousand	29.16 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	112.74 Million	171.5 Million	250.11 Million	-104.94 Million	-45.84 Million	-15.94 Million
Stock Holders Equity	112.74 Million	171.5 Million	250.11 Million	-104.94 Million	-45.84 Million	-15.94 Million
Common Stock	1000.00	-	-	-	-	-
Retained Earnings	-364.28 Million	-295.08 Million	-206.99 Million	-108.39 Million	-47.67 Million	-17.18 Million
Accumulated other comprehensive income	37 Thousand	-919 Thousand	-321 Thousand	-	-	-
Common Stock Equity	112.74 Million	171.5 Million	250.11 Million	-104.94 Million	-45.84 Million	-15.94 Million
Capital Lease Obligation	17.43 Million	22.61 Million	24.35 Million	10.87 Million	10.18 Million	40 Thousand
Total Investments	119.55 Million	183.58 Million	244.18 Million	17.29 Million	584 Thousand	-
Total Debt	20.21 Million	22.61 Million	24.35 Million	10.87 Million	10.18 Million	40 Thousand
Net Debt	9.4 Million	13.36 Million	-3.02 Million	5.33 Million	-24.64 Million	-13.59 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	124.17 Million	142.89 Million	159.78 Million	159.78 Million	175.35 Million	190.69 Million
Total Current Assets	76.63 Million	95.05 Million	105.53 Million	105.53 Million	125.46 Million	130.66 Million
Cash And Short Term Investments	73.69 Million	91.35 Million	102.18 Million	102.18 Million	119.72 Million	125.86 Million
Cash and Cash Equivalents	6.2 Million	4.26 Million	10.81 Million	10.81 Million	9.16 Million	13.45 Million
Short Term Investments	67.49 Million	87.08 Million	91.37 Million	91.37 Million	110.56 Million	112.41 Million
Net Receivables	700 Thousand	900 Thousand	1.3 Million	1.3 Million	2.8 Million	2 Million
Inventory	-	-	-	-	-2.8 Million	-2 Million
Other Current Assets	2.23 Million	2.8 Million	2.04 Million	2.04 Million	5.74 Million	4.8 Million
Total Non-Current Assets	47.54 Million	47.83 Million	54.25 Million	54.25 Million	49.88 Million	60.02 Million
Net PPE	21.63 Million	22.84 Million	24.07 Million	24.07 Million	25.14 Million	26.23 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	25.59 Million	23.22 Million	28.17 Million	28.17 Million	21.63 Million	31.22 Million
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	308 Thousand	1.76 Million	1.99 Million	1.99 Million	3.1 Million	2.57 Million
Other Assets	-	1.00	1.00	1.00	-	-
Total Liabilities	38.31 Million	38.73 Million	47.04 Million	47.04 Million	47.09 Million	48.56 Million
Total Current Liabilities	17.9 Million	16.72 Million	20.45 Million	20.45 Million	18.75 Million	17.61 Million
Account Payables	2.62 Million	2.21 Million	2.98 Million	2.98 Million	3.68 Million	3.43 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	2.99 Million	2.88 Million	2.78 Million	2.78 Million	2.68 Million	2.58 Million
Deferred Revenue	2.02 Million	1.9 Million	2.2 Million	2.2 Million	1.93 Million	1.68 Million
Other Current Liabilities	10.25 Million	9.7 Million	12.48 Million	12.48 Million	10.45 Million	9.91 Million
Total Non Current Liabilities	20.41 Million	22 Million	26.58 Million	26.58 Million	28.34 Million	30.94 Million
Long-Term Debt	15.89 Million	16.68 Million	17.43 Million	17.43 Million	18.17 Million	18.89 Million
Deferred Revenue Non Current	4.52 Million	5.33 Million	9.1 Million	9.1 Million	10.12 Million	12.01 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	4.52 Million	-1.00	43 Thousand	43 Thousand	43 Thousand	43 Thousand
Other Liabilities	-	2.00	-	-	-	-
Total Equity	85.86 Million	104.15 Million	112.74 Million	112.74 Million	128.25 Million	142.13 Million
Stock Holders Equity	85.86 Million	104.15 Million	112.74 Million	112.74 Million	128.25 Million	142.13 Million
Common Stock	1000.00	1000.00	1000.00	1000.00	1000.00	1000.00
Retained Earnings	-396.29 Million	-375.09 Million	-364.28 Million	-364.28 Million	-346.38 Million	-330.12 Million
Accumulated other comprehensive income	-44 Thousand	-36 Thousand	37 Thousand	37 Thousand	-174 Thousand	-229 Thousand
Common Stock Equity	85.86 Million	104.15 Million	112.74 Million	112.74 Million	128.25 Million	142.13 Million
Capital Lease Obligation	15.89 Million	16.68 Million	17.43 Million	17.43 Million	20.85 Million	21.47 Million
Total Investments	93.09 Million	110.31 Million	119.55 Million	119.55 Million	132.2 Million	143.63 Million
Total Debt	18.89 Million	19.56 Million	20.21 Million	20.21 Million	20.85 Million	21.47 Million
Net Debt	12.68 Million	15.3 Million	9.4 Million	9.4 Million	11.69 Million	8.02 Million

Balance Sheet Charts

Exela Technologies, Inc.

XELA

Full Analysis

Annual Balance Sheets
Entrada Therapeutics, Inc.

TRDA

Full Analysis

Annual Balance Sheets
Viasat, Inc.

0LPE

Full Analysis

Annual Balance Sheets
Laser Photonics Corporation

LASE

Full Analysis

Annual Balance Sheets
Uni-President China Holdings Ltd

0220

Full Analysis

Annual Balance Sheets
Empyrean Energy Plc

EME

Full Analysis

Annual Balance Sheets

Global Stocks Search

Bolt Biotherapeutics, Inc. (BOLT)

Annual Balance Sheets

Balance Sheet Charts

Exela Technologies, Inc.

Entrada Therapeutics, Inc.

Viasat, Inc.

Laser Photonics Corporation

Uni-President China Holdings Ltd

Empyrean Energy Plc